» Articles » PMID: 30507612

Lipin 2/3 Phosphatidic Acid Phosphatases Maintain Phospholipid Homeostasis to Regulate Chylomicron Synthesis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2018 Dec 4
PMID 30507612
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The lipin phosphatidic acid phosphatase (PAP) enzymes are required for triacylglycerol (TAG) synthesis from glycerol 3-phosphate in most mammalian tissues. The 3 lipin proteins (lipin 1, lipin 2, and lipin 3) each have PAP activity, but have distinct tissue distributions, with lipin 1 being the predominant PAP enzyme in many metabolic tissues. One exception is the small intestine, which is unique in expressing exclusively lipin 2 and lipin 3. TAG synthesis in small intestinal enterocytes utilizes 2-monoacylglycerol and does not require the PAP reaction, making the role of lipin proteins in enterocytes unclear. Enterocyte TAGs are stored transiently as cytosolic lipid droplets or incorporated into lipoproteins (chylomicrons) for secretion. We determined that lipin enzymes are critical for chylomicron biogenesis, through regulation of membrane phospholipid composition and association of apolipoprotein B48 with nascent chylomicron particles. Lipin 2/3 deficiency caused phosphatidic acid accumulation and mammalian target of rapamycin complex 1 (mTORC1) activation, which were associated with enhanced protein levels of a key phospholipid biosynthetic enzyme (CTP:phosphocholine cytidylyltransferase α) and altered membrane phospholipid composition. Impaired chylomicron synthesis in lipin 2/3 deficiency could be rescued by normalizing phospholipid synthesis levels. These data implicate lipin 2/3 as a control point for enterocyte phospholipid homeostasis and chylomicron biogenesis.

Citing Articles

LPIN3 promotes colorectal cancer growth by dampening intratumoral CD8 T cell effector function.

Zhang X, Fang H, Wu W, Jiang C, Wang H, Shi Y Cancer Immunol Immunother. 2025; 74(4):135.

PMID: 40042548 PMC: 11883066. DOI: 10.1007/s00262-025-03989-2.


Diacylglycerol Kinases and Its Role in Lipid Metabolism and Related Diseases.

Liu Y, Yang Z, Zhou X, Li Z, Hideki N Int J Mol Sci. 2024; 25(23).

PMID: 39684917 PMC: 11643042. DOI: 10.3390/ijms252313207.


Phosphatidic acid is an endogenous negative regulator of PIEZO2 channels and mechanical sensitivity.

Gabrielle M, Yudin Y, Wang Y, Su X, Rohacs T Nat Commun. 2024; 15(1):7020.

PMID: 39147733 PMC: 11327303. DOI: 10.1038/s41467-024-51181-4.


Haploinsufficiency of Lipin3 leads to hypertriglyceridemia and obesity by disrupting the expression and nucleocytoplasmic localization of Lipin1.

Wang F, Liu Y, Dong Y, Zhao M, Huang H, Jin J Front Med. 2023; 18(1):180-191.

PMID: 37776435 DOI: 10.1007/s11684-023-1003-0.


Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting the glycerophospholipid metabolism pathway.

Yan B, Yuan S, Cao J, Fung K, Lai P, Yin F Int J Biol Sci. 2022; 18(12):4744-4755.

PMID: 35874954 PMC: 9305268. DOI: 10.7150/ijbs.73057.


References
1.
Johnston J, Rao G, Lowe P, Schwarz B . The nature of the stimulatory role of the supernatant fraction on triglyceride synthesis by the alpha-Glycerophosphate pathway. Lipids. 1967; 2(1):14-20. DOI: 10.1007/BF02531994. View

2.
Buhman K, Smith S, Stone S, Repa J, Wong J, Knapp Jr F . DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J Biol Chem. 2002; 277(28):25474-9. DOI: 10.1074/jbc.M202013200. View

3.
Raabe M, Veniant M, Sullivan M, Zlot C, Bjorkegren J, Nielsen L . Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest. 1999; 103(9):1287-98. PMC: 408359. DOI: 10.1172/JCI6576. View

4.
Rong X, Wang B, Dunham M, Hedde P, Wong J, Gratton E . Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion. Elife. 2015; 4. PMC: 4400582. DOI: 10.7554/eLife.06557. View

5.
Hamilton R, Wong J, Cham C, Nielsen L, Young S . Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. J Lipid Res. 1998; 39(8):1543-57. View